Barnes A D
Postgrad Med J. 1976;52(5 Suppl):110-1.
Antithymocyte globulin (ATG) has been used to treat three female patients with myastenia gravis. No other immunosuppressive agent was used. All three cases responded favourably to ATG therapy. This suggest that further work should be undertaken in this field though the condition itself is extremely variable and this study was not controlled.
抗胸腺细胞球蛋白（ATG）已被用于治疗3例重症肌无力女性患者。未使用其他免疫抑制剂。所有3例患者对ATG治疗反应良好。这表明尽管病情本身差异极大且本研究未设对照，但仍应在该领域开展进一步研究。
